FAK activation drives non-genetic adaptive survival of ALK-rearranged lung cancer under tyrosine kinase inhibitor treatment

Journal of Genetics and Genomics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles